Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases.
Nanograb has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2023.
Nanograb's investors include Y Combinator.
Nanograb is headquartered in San Francisco, United States.
Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases.
Nanograb is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nanograb — Funding & Investors." VCBacked, September 6, 2023, https://www.vcbacked.co/company/nanograb. Accessed August 1, 2026.
VCBacked. (2023). Nanograb — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/nanograb
{{cite web |title=Nanograb — Funding & Investors |url=https://www.vcbacked.co/company/nanograb |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated